02005 石四藥集團
按盤價 
2.970 -0.040 (-1.329%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 01/04/2025 | 曲繼廣 | 1113(L) | +3,000,000(L) | HKD3.363(L) | 1,152,226,000(L) | 39.01 |
| 01/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +3,000,000(L) | HKD3.363(L) | 862,988,000(L) | 29.22 |
| 01/04/2025 | 曲繼廣 | 1101(L) | +1,400,000(L) | HKD3.374(L) | 1,153,626,000(L) | 39.05 |
| 31/03/2025 | China Pharmaceutical Company Limited | 1710(L) | +2,800,000(L) | HKD3.191(L) | 859,988,000(L) | 29.11 |
| 31/03/2025 | 曲繼廣 | 1113(L) | +2,800,000(L) | HKD3.191(L) | 1,149,226,000(L) | 38.90 |
| 21/02/2025 | UBS Group AG | 1201(L) | -372,000(L) | HKD3.244(L) | 265,496,063(L) | 8.98 |
| 20/02/2025 | UBS Group AG | 1101(L) | +198,000(L) | HKD3.335(L) | 265,867,466(L) | 9.00 |
| 18/02/2025 | UBS Group AG | 1201(L) | -448,204(L) | HKD3.238(L) | 265,697,464(L) | 8.99 |
| 08/01/2025 | 曲繼廣 | 1113(L) | +500,000(L) | HKD3.263(L) | 1,146,426,000(L) | 38.76 |
| 08/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD3.263(L) | 857,188,000(L) | 28.98 |
| 07/01/2025 | 曲繼廣 | 1113(L) | +600,000(L) | HKD3.337(L) | 1,145,926,000(L) | 38.74 |
| 07/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +600,000(L) | HKD3.337(L) | 856,688,000(L) | 28.96 |
| 06/01/2025 | 曲繼廣 | 1113(L) | +600,000(L) | HKD3.388(L) | 1,145,326,000(L) | 38.72 |
| 06/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +600,000(L) | HKD3.388(L) | 856,088,000(L) | 28.94 |
| 03/01/2025 | 曲繼廣 | 1113(L) | +660,000(L) | HKD3.372(L) | 1,144,726,000(L) | 38.70 |
| 03/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +660,000(L) | HKD3.372(L) | 855,488,000(L) | 28.92 |
| 26/11/2024 | 曲繼廣 | 1101(L) | +1,300,000(L) | HKD3.490(L) | 1,144,066,000(L) | 38.68 |
| 20/11/2024 | 曲繼廣 | 1101(L) | +400,000(L) | HKD3.880(L) | 1,142,766,000(L) | 38.63 |
| 19/11/2024 | 曲繼廣 | 1101(L) | +900,000(L) | HKD3.772(L) | 1,142,366,000(L) | 38.62 |
| 15/11/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.807(L) | 854,828,000(L) | 28.90 |
| 15/11/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD3.807(L) | 1,141,466,000(L) | 38.59 |
| 14/11/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.817(L) | 853,828,000(L) | 28.87 |
| 14/11/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD3.817(L) | 1,140,466,000(L) | 38.56 |
| 06/11/2024 | UBS Group AG | 1104(L) | +34,000(L) | 295,795,721(L) | 10.00 | |
| 05/11/2024 | UBS Group AG | 1201(L) | -62,000(L) | HKD3.820(L) | 295,775,721(L) | 9.99 |
| 01/11/2024 | UBS Group AG | 1104(L) | +1,073,732(L) | 296,837,530(L) | 10.04 | |
| 30/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +780,000(L) | HKD3.718(L) | 852,828,000(L) | 28.83 |
| 30/10/2024 | 曲繼廣 | 1113(L) | +780,000(L) | HKD3.718(L) | 1,139,466,000(L) | 38.52 |
| 29/10/2024 | 曲繼廣 | 1113(L) | +1,280,000(L) | HKD3.753(L) | 1,138,686,000(L) | 38.50 |
| 29/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,280,000(L) | HKD3.753(L) | 852,048,000(L) | 28.81 |
| 21/10/2024 | 曲繼廣 | 1113(L) | +800,000(L) | HKD3.898(L) | 1,137,406,000(L) | 38.45 |
| 21/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +800,000(L) | HKD3.898(L) | 850,768,000(L) | 28.76 |
| 17/10/2024 | UBS Group AG | 1205(L) | -300,000(L) | 295,665,644(L) | 9.99 | |
| 16/10/2024 | UBS Group AG | 1104(L) | +980,000(L) | 296,385,646(L) | 10.02 | |
| 14/10/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD4.137(L) | 1,136,606,000(L) | 38.42 |
| 14/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD4.137(L) | 849,968,000(L) | 28.73 |
| 08/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +800,000(L) | HKD4.358(L) | 848,968,000(L) | 28.70 |
| 08/10/2024 | 曲繼廣 | 1113(L) | +800,000(L) | HKD4.358(L) | 1,135,606,000(L) | 38.39 |
| 04/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +300,000(L) | HKD4.421(L) | 848,168,000(L) | 28.67 |
| 04/10/2024 | 曲繼廣 | 1113(L) | +300,000(L) | HKD4.421(L) | 1,134,806,000(L) | 38.36 |
| 1 2 3 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 19/09/2025 14:24 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
